ROZANOLIXIZUMAB
UNII P7186074QC

Substance Identification & Data

This profile provides standardized clinical and technical data for Rozanolixizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P7186074QC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1584645-37-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P7186074QC

CAS Registry Number

1584645-37-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROZANOLIXIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

P7186074QC

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C152270

National Cancer Institute reference terminology for clinical and research data.

INN ID

10213

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-43

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rozanolixizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROZANOLIXIZUMAB

ROZANOLIXIZUMAB-NOLI

Common Names & Synonyms

ROZANOLIXIZUMAB [INN]

ROZANOLIXIZUMAB [JAN]

ROZANOLIXIZUMAB [USAN]

ROZANOLIXIZUMAB [WHO-DD]

ROZANOLIXIZUMAB NOLI [WHO-DD]

Brand / Trade Names

RYSTIGGO

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(HUMAN FCRN RECEPTOR) (HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB 7665 HEAVY CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB 7665 LIGHT CHAIN, DIMER

SYS